RAP 0.00% 20.5¢ resapp health limited

2020 commercialisation, page-603

  1. 2,737 Posts.
    lightbulb Created with Sketch. 1317
    FDA was a balls up...but door is still ajar. IMO we don't want to go back to them prematurely...all these trials etc will build a portfolio of evidence for our Benefits vs Risk proposition.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.